1.Murphy SJ, Aubry MC, Harris FR, Halling GC, Johnson SH, Terra S, Drucker TM, Asiedu MK, Kipp BR, Yi ES et al: Identification of independent primary tumors and intrapulmonary metastases using DNA rearrangements in non-small-cell lung cancer. J Clin Oncol 2014, 32(36):4050–4058.
2.Martini N, Melamed MR: Multiple primary lung cancers. The Journal of thoracic and cardiovascular surgery 1975, 70(4):606–612.
3.Kozower BD, Larner JM, Detterbeck FC, Jones DR: Special treatment issues in non-small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 2013, 143(5 Suppl):e369S-e399S.
4.Waller DA: Surgical management of lung cancer with multiple lesions: implication of the new recommendations of the 8(th) edition of the TNM classification for lung cancer. Journal of thoracic disease 2018, 10(Suppl 22):S2686-S2691.
5.Hamaji M, Ali SO, Burt BM: A meta-analysis of resected metachronous second non-small cell lung cancer. The Annals of thoracic surgery 2015, 99(4):1470–1478.
6.Leventakos K, Peikert T, Midthun DE, Molina JR, Blackmon S, Nichols FC, Garces YI, Hallemeier CL, Murphy SJ, Vasmatzis G et al: Management of Multifocal Lung Cancer: Results of a Survey. J Thorac Oncol 2017, 12(9):1398–1402.
7.NCCN Clinical Practice Guidelines in Oncology: Non-Small Cell Lung Cancer [https://www.nccn.org/professionals/physician_gls/pdf/nscl.pdf]
8.Jiang G, Chen C, Zhu Y, Xie D, Dai J, Jin K, Shen Y, Wang H, Li H, Zhang L et al: [Shanghai Pulmonary Hospital Experts Consensus on the Management of Ground-Glass Nodules Suspected as Lung Adenocarcinoma (Version 1)]. Zhongguo Fei Ai Za Zhi 2018, 21(3):147–159.
9.Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JP, Clarke M, Devereaux PJ, Kleijnen J, Moher D: The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. Bmj 2009, 339:b2700.
10.Parmar MK, Torri V, Stewart L: Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Stat Med 1998, 17(24):2815–2834.
11.van Rens MT, Zanen P, Brutel de La Riviere A, Elbers HR, van Swieten HA, van Den Bosch JM: Survival in synchronous vs. single lung cancer: upstaging better reflects prognosis. Chest 2000, 118(4):952–958.
12.Doddoli C, Thomas P, Ghez O, Giudicelli R, Fuentes P: Surgical management of metachronous bronchial carcinoma. European journal of cardio-thoracic surgery: official journal of the European Association for Cardio-thoracic Surgery 2001, 19(6):899–903.
13.Trousse D, Barlesi F, Loundou A, Tasei AM, Doddoli C, Giudicelli R, Astoul P, Fuentes P, Thomas P: Synchronous multiple primary lung cancer: an increasing clinical occurrence requiring multidisciplinary management. The Journal of thoracic and cardiovascular surgery 2007, 133(5):1193–1200.
14.Xiao F, Liu D, Liang C: Survival and prognostic factors of synchronous multiple primary NSCLC and further differentiation from intrapulmonary metastasis. Journal of Thoracic Oncology 2017, 12(11):S2354-S2355.
15.Riquet M, Cazes A, Pfeuty K, Ngabou UD, Foucault C, Dujon A, Banu E: Multiple lung cancers prognosis: what about histology? The Annals of thoracic surgery 2008, 86(3):921–926.
16.Hamaji M, Allen MS, Cassivi SD, Deschamps C, Nichols FC, Wigle DA, Shen KR: Surgical treatment of metachronous second primary lung cancer after complete resection of non-small cell lung cancer. The Journal of thoracic and cardiovascular surgery 2013, 145(3):683–690; discussion 690–681.
17.Voltolini L, Rapicetta C, Luzzi L, Ghiribelli C, Paladini P, Granato F, Gallazzi M, Gotti G: Surgical treatment of synchronous multiple lung cancer located in a different lobe or lung: high survival in node-negative subgroup. European journal of cardio-thoracic surgery: official journal of the European Association for Cardio-thoracic Surgery 2010, 37(5):1198–1204.
18.De Leyn P, Moons J, Vansteenkiste J, Verbeken E, Van Raemdonck D, Nafteux P, Decaluwe H, Lerut T: Survival after resection of synchronous bilateral lung cancer. European journal of cardio-thoracic surgery: official journal of the European Association for Cardio-thoracic Surgery 2008, 34(6):1215–1222.
19.Ishikawa Y, Nakayama H, Ito H, Yokose T, Tsuboi M, Nishii T, Masuda M: Surgical treatment for synchronous primary lung adenocarcinomas. The Annals of thoracic surgery 2014, 98(6):1983–1988.
20.Lee BE, Port JL, Stiles BM, Saunders J, Paul S, Lee PC, Altorki N: TNM stage is the most important determinant of survival in metachronous lung cancer. The Annals of thoracic surgery 2009, 88(4):1100–1105.
21.Travis WD, Brambilla E, Noguchi M, Nicholson AG, Geisinger KR, Yatabe Y, Beer DG, Powell CA, Riely GJ, Van Schil PE et al: International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma. J Thorac Oncol 2011, 6(2):244–285.
22.Nakamura H, Kawasaki N, Taguchi M, Kabasawa K: Survival following lobectomy vs limited resection for stage I lung cancer: a meta-analysis. British journal of cancer 2005, 92(6):1033–1037.
23.Fan J, Wang L, Jiang GN, Gao W: Sublobectomy versus lobectomy for stage I non-small-cell lung cancer, a meta-analysis of published studies. Ann Surg Oncol 2012, 19(2):661–668.
24.Altorki NK, Yip R, Hanaoka T, Bauer T, Aye R, Kohman L, Sheppard B, Thurer R, Andaz S, Smith M et al: Sublobar resection is equivalent to lobectomy for clinical stage 1A lung cancer in solid nodules. The Journal of thoracic and cardiovascular surgery 2014, 147(2):754–762; Discussion 762–754.
25.Khullar OV, Liu Y, Gillespie T, Higgins KA, Ramalingam S, Lipscomb J, Fernandez FG: Survival After Sublobar Resection versus Lobectomy for Clinical Stage IA Lung Cancer: An Analysis from the National Cancer Data Base. J Thorac Oncol 2015, 10(11):1625–1633.
26.Fonseca A, Detterbeck FC: How many names for a rose: inconsistent classification of multiple foci of lung cancer due to ambiguous rules. Lung cancer (Amsterdam, Netherlands) 2014, 85(1):7–11.
27.Koike T, Koike T, Yoshiya K, Tsuchida M, Toyabe S: Risk factor analysis of locoregional recurrence after sublobar resection in patients with clinical stage IA non-small cell lung cancer. The Journal of thoracic and cardiovascular surgery 2013, 146(2):372–378.
28.Sihoe ADL, Van Schil P: Non-small cell lung cancer: When to offer sublobar resection. Lung cancer (Amsterdam, Netherlands) 2014, 86(2):115–120.